Echinocandins: a new class of antifungal

被引：225

作者：

Denning, DW

机构：

[1] Wythenshawe Hosp, Educ & Res Ctr, Manchester M23 9LT, Lancs, England

[2] Univ Manchester, Manchester M13 9PL, Lancs, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 49卷 / 06期

关键词：

D O I：

10.1093/jac/dkf045

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

[No abstract available]

引用

页码：889 / 891

页数：3

共 15 条

[1]

Balani SK, 2000, DRUG METAB DISPOS, V28, P1274

[2] In vitro preclinical evaluation studies with the echinocandin antifungal MK-0991 (L-743,872) [J].

Bartizal, K ;

Gill, CJ ;

Abruzzo, GK ;

Flattery, AM ;

Kong, L ;

Scott, PM ;

Smith, JG ;

Leighton, CE ;

Bouffard, A ;

Dropinski, JF ;

Balkovec, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (11) :2326-2332

[3] Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis:: Demonstration of efficacy of caspofungin acetate [J].

Bowman, JC ;

Abruzzo, GK ;

Anderson, JW ;

Flattery, AM ;

Gill, CJ ;

Pikounis, VB ;

Schmatz, DM ;

Liberator, PA ;

Douglas, CM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) :3474-3481

[4] Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts [J].

Espinel-Ingroff, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :2950-2956

[5] The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans [J].

Feldmesser, M ;

Kress, Y ;

Mednick, A ;

Casadevall, A .

JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) :1791-1795

[6] Prophylactic effect of FK463, a novel antifungal lipopeptide, against Pneumocystis carinii infection in mice [J].

Ito, M ;

Nozu, R ;

Kuramochi, T ;

Eguchi, N ;

Suzuki, S ;

Hioki, K ;

Itoh, T ;

Ikeda, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (09) :2259-2262

[7] Efficacy of FK463, a (1,3)-β-D-glucan synthase inhibitor, in disseminated azole-resistant Candida albicans infection in mice [J].

Maesaki, S ;

Hossain, MA ;

Miyazaki, Y ;

Tomono, K ;

Tashiro, T ;

Kohno, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (06) :1728-1730

[8] In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species [J].

Moore, CB ;

Oakley, KL ;

Denning, DW .

CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (01) :11-16

[9] In vitro activity of the echinocandin antifungal agent LY303,366 in comparison with itraconazole and amphotericin B against Aspergillus spp. [J].

Oakley, KL ;

Moore, CB ;

Denning, DW .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (10) :2726-2730

[10] Antifungal efficacy of caspofungin (MK-0991) in experimental pulmonary aspergillosis in persistently neutropenic rabbits: Pharmacokinetics, drug disposition, and relationship to galactomannan antigenemia [J].

Petraitiene, R ;

Petraitis, V ;

Groll, AH ;

Sein, T ;

Schaufele, RL ;

Francesconi, A ;

Bacher, J ;

Avila, NA ;

Walsh, TJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (01) :12-23

← 1 2 →